BNEC is one of the most malignant tumors with severe invasiveness and poor prognosis. Immunohistochemistry revealed that CD56, Syn, CgA, NSE, TTF-1, CK, CK7, CK20, P63, HMB45, S-100 protein and LCA immune markers play important roles in diagnosis and differentiation. Many factors, including the patient's age, size and shape of the tumor, operative method, perineuronal invasion, vascular invasion, distant organ metastasis and pathological type, show great difference in influencing OS time of patients, among which the size of the tumor, no invasion, vascular invasion and distant organ metastasis are independent risk factors affecting prognosis (survival time). Radical cystectomy is the prior alternative to treat this tumor.
This study aimed to improve the diagnostic accuracy of breast diseases by combining breast imaging–reporting and data system (BI–RADS) with the enhancement intensity and pattern of contrast-enhanced spectral mammography (CESM) (this combination of BI–RADS and CESM was designated as BaC). BI–RADS was used to evaluate low-energy CESM images. Spearman nonparametric correlation analysis was performed to analyze the correlation between the enhancement intensity of CESM subtraction images and the pathological results. Odds ratio (OR) values were calculated to determine whether the enhancement pattern of CESM subtraction images is a risk factor for benign and malignant lesions. The diagnostic efficacies of BI–RADS, CESM, and BaC scores for benign and malignant breast diseases were analyzed using the receiver operating characteristic (ROC) curve. Lesions with a high enhancement intensity were more likely to be malignant than those with low enhancement intensity. Lesions with heterogeneous enhancement tended to be malignant, whereas those with homogeneous enhancement tended to be benign. No significant correlation was observed between ring enhancement and the benignity or malignancy of lesions. The area under the ROC curve of BaC was higher than that of BI–RADS or CESM, and the difference was statistically significant. The diagnostic efficacy of BI–RADS combined with CESM enhancement was superior to that of either method alone.
Abstract. Retroperitoneal cystic immature teratoma (RCIT) is a rare disease. RCITs manifest as solid and cystic masses. In pathological sections, cysts of various sizes, with internal hemorrhage and necrosis, are observed. Components of all germ layer tissue are also observed, the majority of which is located within the endoderm. As the tumor contains undifferentiated immature tissue components, RCITs are also termed malignant teratomas. Immature teratomas grow rapidly, often invading adjacent tissue to cause serious symptoms, and transfer through the blood and lymph vessels, often resulting in glandular cancer. The present study reports the case of an infant with RCIT. The female patient, aged six months and six days, was hospitalized due to an abdominal mass. Physical examination revealed a large mass (10x8 cm) below the xiphoid in the epigastrium. The mass, which ranged from the xiphoid to the umbilical region, was friable, and possessed a smooth surface, clear boundaries and poor activity, without tenderness. Upper abdominal computed tomography (CT) revealed a large, solid, cystic mass in the left, middle and lower retroperitoneum. The patient was admitted to the Yantai Yuhuangding Hospital for surgery. The pre-operative examination was improved following admission by documenting parameters that included the results from routine blood tests, bleeding and clotting times and cardiography. Retroperitoneal tumor resection was then performed. During resection, the tumor was found to originate from the retroperitoneum. As the tumor involved the gastric wall, a section of the gastric wall was resected, in addition to the tumor. The resection surface was yellow and friable. Pathological examination of tumor tissue sections revealed the involvement of immature nerves and mesenchymal components, confirming the diagnosis of a grade II immature teratoma. Subsequent to six months of outpatient follow-up, the patient had recovered well, without recurrence. RCIT is a clinically rare disease, and the present study adds to the current understanding of this rare condition in infants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.